TITLE 34. PUBLIC FINANCE

PART 1. COMPTROLLER OF PUBLIC ACCOUNTS

CHAPTER 16. COMPTROLLER GRANT PROGRAMS

SUBCHAPTER C. TEXAS OPIOID ABATEMENT FUND PROGRAM

34 TAC §§16.200, 16.208, 16.211

The Comptroller of Public Accounts adopts amendments to §16.200, concerning definitions, §16.208, concerning grant application review, and §16.211, concerning allowable costs, without changes to the proposed text as published in the May 16, 2025, issue of the Texas Register (50 TexReg 2950). The rules will not be republished.

The comptroller amends these sections to make the Opioid Abatement Fund Council's evaluation and review of grant applications more efficient and to prevent excessive costs due to the external peer review of large numbers of grant applications.

The amendments to §16.200 update definitions.

The amendments to §16.208(a) change the application review process to allow grant applications to either be reviewed internally by program staff or through a peer review process based on the value of the grant.

The amendments to §16.211(b) change the grant disbursement process to allow the council to disburse funds on a reimbursement or on an as needed basis as determined by the council to effectuate the purposes of the grant.

The comptroller did not receive any comments regarding adoption of the amendments.

The amendments are adopted under Government Code, §403.511, which authorizes the comptroller to adopt rules to implement Government Code, Chapter 403, Subchapter R, concerning the statewide opioid settlement agreement.

The amendments implement Government Code, Chapter 403, Subchapter R, concerning the statewide opioid settlement agreement.

The agency certifies that legal counsel has reviewed the adoption and found it to be a valid exercise of the agency's legal authority.

Filed with the Office of the Secretary of State on September 11, 2025.

TRD-202503234

Victoria North

General Counsel for Fiscal and Agency Affairs

Comptroller of Public Accounts

Effective date: October 1, 2025

Proposal publication date: May 16, 2025

For further information, please call: (512) 475-2220